Cardiol Therapeutics Inc. (CRDL) stock
CRDLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.86−0.02 (-2.28%)
Close on Nov 20, 2026Market cap $86.48MP/E –Yield –
Cardiol Therapeutics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2021 it was C$78.76K.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | C$78.76K | – |
See a number that looks wrong?